Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Duke University
- Stanford University
- Virginia Tech
- Delft University of Technology (TU Delft)
- EPFL
- Institut Pasteur
- Institute for bioengineering of Catalonia, IBEC
- University of Nebraska Medical Center
- University of Oxford
- Yale University
- Aarhus University
- CNRS
- Carnegie Mellon University
- Cornell University
- Institute of Physical Chemistry, Polish Academy of Sciences
- Lunds universitet
- SUNY University at Buffalo
- Technical University of Munich
- University of Colorado
- University of Gdansk
- University of Maryland, Baltimore
- University of Southern California
- University of Sydney
- University of Washington
- CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences
- Computer Vision Center
- ICN2
- Indiana University
- Institut d’Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI-CERCA)
- Institute of Geological Sciences, Polish Academy of Sciences
- Josep Carreras Leukaemia Research Institute (IJC)
- KU Leuven
- Karolinska Institutet (KI)
- Linköping University
- Max Planck Institute of Molecular Cell Biology and Genetics, Dresden
- NEW YORK UNIVERSITY ABU DHABI
- Northeastern University
- Oak Ridge National Laboratory
- Princess Máxima Center for Pediatric Oncology
- Queen Mary University of London
- Radboud University Medical Center (Radboudumc)
- Research Center for Molecular Medicine (CeMM), ÖAW
- Ryerson University
- SciLifeLab
- Swarthmore College
- Texas A&M AgriLife
- The Rosalind Franklin Institute
- Universitat de Barcelona
- University of Cambridge;
- University of Central Florida
- University of Florida
- University of Illinois
- University of Liverpool
- University of Luxembourg
- University of Miami
- University of North Carolina at Chapel Hill
- University of Oregon
- University of Pittsburgh
- University of Southern California - Center for Craniofacial Molecular Biology
- Yale School of Medicine - Department of Genetics
- 50 more »
- « less
-
Field
-
biomaterial-based drug delivery systems and engineered tissue platforms to understand and modulate cell–material interactions, protect tissues from injury and disease, and promote tissue repair and regeneration
-
evaluations, and tissue collections for biochemical, immunological, histological analyses. The work also requires extensive data analysis with molecular, cellular and biochemical assays on cultured cells and
-
Qualifications: Applicants should hold a PhD or MD/PhD in cancer biology, molecular and cellular biology, biomedical engineering, bioengineering, or a related field. Strong training and research experience in
-
and compliance, data analysis, and dissemination of findings through manuscripts and presentations. Minimum Requirements • PhD in biofabrication, biomedical engineering, chemistry/materials science
-
multi-scale approach investigates joint health and disease at the cellular-, tissue-, joint-, whole person-, and societal-levels. The Biomechanical engineering department at TU Delft is seeking a talented
-
Information Eligibility criteria Education: PhD in tissue engineering, bioengineering or cell biology. Technical skills: experience in cell culture and organoid production, immunolabelling, PCR. Microfluidics
-
an original minimally invasive microscope to characterize cellular morphology and health of engineered heart tissue. The new system, called In-vivo Scope, will synergistically combine ultrasound with optical
-
. Physics, Engineering, Computer Sciences, Neurosciences), and a PhD in a relevant computational domain. Also deep knowledge of statistics and Bayesian learning, and necessary mathematical and computational
-
tissue engineering is desired. This is an outstanding opportunity for persons interested in ultimately pursuing a medical and/or bioengineering career path. Applicants must have a PhD, and/or MD
-
lab members, the group's organoid/tissue-engineered infection models (airway, gut) to prioritize physiologically relevant hits Co-supervise PhD students and contribute to method development, data